?
The “Search” function is not available at the moment, please try again later.
Please get in contact with us. To contact form

Helvetia Annual General Meeting confirms all proposals of the Board of Directors

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW
25.04.2025 | Media release
helvetia_gv_250420251.jpg

The shareholders of Helvetia Holding Ltd approved all proposals put forward by the Board of Directors at the company’s Annual General Meeting. The Chair and other members of the Board of Directors standing for election were re-elected. Dr Andreas von Planta stepped down from the Board on age grounds.

The Chair of the Board of Directors, Dr Thomas Schmuckli, welcomed 2,410 shareholders with voting rights (representing 65.73% of share capital) to Helvetia Holding Ltd’s 29th ordinary Annual General Meeting held at the Olma Messen St.Gallen venue. Fabian Rupprecht, Group CEO of Helvetia, presented the 2024 financial results. Helvetia successfully continued on its selective growth path with a focus on profitable and capital-efficient business fields and increased its business volume by 3.1% to CHF 11,552.7 million on a currency-adjusted basis (2023: CHF 11,311.3 million). The Helvetia Group generated underlying earnings of CHF 528.5 million, which represents an increase of 41.9% compared to the previous year (2023: CHF 372.5 million).
 
"Thanks to its focus on profitable and capital-efficient business fields, Helvetia was able to perform well in the 2024 financial year. A notable highlight is the strong growth recorded in the attractive non-life business. With our new strategy, we will build on our strong foundation and continue to focus on technical profitability and operating efficiency", explained Fabian Rupprecht at the Annual General Meeting.
 
Focus on new strategy
Helvetia unveiled its new strategy in December 2024 as part of its Capital Markets Day. Dr Thomas Schmuckli, Chairman of the Board of Directors, presented the content of the new strategy to shareholders, including the planned merger with Baloise, which both companies announced on Tuesday and which will be voted on at an extraordinary shareholders' meeting on 23 May 2025: "The strategies of the two companies complement each other very well. Both focus on customers and place a strong focus on operational efficiency and technical excellence. Together, Helvetia and Baloise will become a leading European insurance company with strong Swiss roots." 
 
Dividend increase of 40 centimes
Based on Helvetia’s profitable growth and resilient result in the 2024 financial year, as well as the Group’s continued strong capitalisation, the Board of Directors proposed to the Annual General Meeting that the dividend be increased by 40 centimes to CHF 6.70 per share. The shareholders approved this proposal. Helvetia is therefore continuing its attractive dividend policy of recent years. 
 
Dr Thomas Schmuckli confirmed as Chair of Board of Directors 
The Annual General Meeting confirmed Dr Thomas Schmuckli as Chair of the Board of Directors. All other members of the Board of Directors standing for election were also re-elected. Dr. Andreas von Planta did not put himself forward for re-election as he will soon reach the age limit stipulated in the Organization Rules.
 
Compensation approved
The shareholders also approved the total amounts of fixed compensation for the members of the Board of Directors and the fixed and variable compensation for the Executive Management. In addition, Walter Wagner, a lawyer and notary from St. Gallen, was elected as independent proxy. KPMG AG, Zurich, was once again confirmed as auditor.


Contact information
Analysts
Peter Eliot
Head of Investor Relations
Phone: +41 58 280 59 19
investor.relations@helvetia.ch
Media
Jonas Grossniklaus
Head of Corporate Communications
Phone: +41 58 280 50 33
media.relations@helvetia.ch